Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kalo Gold Discovers Seven Epithermal Gold Targets Along the 100% Owned, District-Scale Namalau Trend, Vatu Aurum Project, Fiji
-
Company Distilling Unveils Ghost Rail Heirloom Gin, Bringing a Unique Spirit to Both Gin and Whiskey Lovers Alike
-
Jersey Mike's Subs Donates 20 Percent of Sales To Best Buddies International This Weekend
-
Global Digital Asset-Based Exchange Traded Products AUM Reaches All-Time High of $100 Billion
-
HydrogenPro ASA - Invitation to Q3 2024 webcast
-
R3’s Corda selected as first authorized DLT platform for European DLT Pilot Regime
-
AIGC | If Shakespeare encountered Tang Xianzu in Jiangxi
-
Sunrise Realty Trust, Inc. Announces Financial Results for Third Quarter 2024
-
Alliance Witan PLC - Net Asset Value
-
Volta Agrees to Acquire the ZigZag Lithium Project Contiguous to Its Falcon West Lithium Discovery in Ontario
-
Vext to Announce Financial Results for Q3 2024 on November 21, 2024
-
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
-
A2Z Cust2Mate Solutions Corp. to Participate in 13th Annual ROTH Technology Conference November 19-20, 2024
-
Founders Metals Hits New Discovery in Third Lower Antino Drill Hole
-
ALX Resources Corp. Announces Filing and Mailing of the Management Information Circular in Connection with Its Annual and Special Meeting of Shareholders to Approve the Acquisition of the Company by G
-
QuantGate Announces Successful Strategic Global Partnership with Yosef Cohen
-
Ridgeline Minerals and Nevada Gold Mines Drill High-Grade "Carlin-Type" Gold Mineralization at the Swift Project, Nevada
-
Angus Gold to Present at the 2024 Precious Metals Summit Zurich and Participate in the 121 Mining Investment Conference
-
CRH plc (the "Company") Form 10-Q for the quarterly period ended September 30, 2024
-
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
-
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Condor to Present Its Energy Transition Initiatives at COP29 in Baku, Azerbaijan
-
Cars.com Reports Third Quarter 2024 Results
-
Knight Therapeutics Reports Third Quarter 2024
-
Kelly Reports Third-Quarter 2024 Earnings
-
Ping An Takes Lead in Fortune Fintech Innovator Asia list, Ranked 1st in Insurtech
-
CME Group Declares Quarterly Dividend
-
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
-
Allstate and Arlo Team Up to Boost Home Protection Just in Time for The Holidays
-
SolarBank Expands into the projected $395 Billion Data Center Market as Developer and Strategic Partner
-
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
-
UScellular announces sale of select spectrum assets to AT&T for $1.018 billion
-
Zimmer Biomet to Present at Jefferies London Healthcare Conference
-
Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Else Nutrition Launches 12-Week Pilot in Canada with Multinational Wholesale Retailer
-
Fidelity National Financial Announces 4% Increase in Quarterly Cash Dividend
-
ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update
-
Nova Reports Record Third Quarter 2024 Financial Results
-
F&G Annuities & Life Announces 5% Increase in Quarterly Common Stock Dividend And Declares Dividend on Preferred Stock
-
TEGNA Inc. Reports Third Quarter 2024 Results and Provides Fourth Quarter 2024 Guidance
-
Hilton Grand Vacations Reports Third Quarter 2024 Results
-
ANYWHERE REAL ESTATE INC. REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Signet Jewelers Announces Timing of Fiscal 2025 Third Quarter Earnings Release and Conference Call
-
Turning Point Brands Announces Third Quarter 2024 Results
-
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
-
iHeartMedia Enters into Transaction Support Agreement to Strengthen Balance Sheet
-
Thryv Accelerates SaaS Revenue Growth and Achieves the "Rule of 40¹" in Third Quarter 2024
-
Installed Building Products Reports Record Third Quarter 2024 Results; Declares Regular Quarterly Cash Dividend
-
Priority Technology Holdings, Inc. Announces Third Quarter Financial Results
